technetium has been researched along with Carcinoma in Situ in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baum, RP; Borrón, M; Díaz, N; Oliva, JP; Oliver, B; Ortiz, R; Peralta, R; Pimentel, G; Sánchez, I; Vázquez, AM | 1 |
1 trial(s) available for technetium and Carcinoma in Situ
Article | Year |
---|---|
[Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Antibodies, Heterophile; Antibodies, Monoclonal; Antigens, Neoplasm; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma in Situ; Colorectal Neoplasms; Epitopes; Female; Humans; Immunoconjugates; Immunoglobulin G; Male; Mice; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radioimmunodetection; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon | 2001 |